Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics
Report Scope
This report provides a comprehensive summary of the polymerase chain reaction (PCR) for point-of-care (POC) diagnostics, along with a detailed competitive landscape and profiles of key market players that include revenue, product portfolios and recent activities. The report analyzes trends and dynamics, including drivers, limitations, challenges, and opportunities. This research study discusses historical, current and potential market size. It will enable market players and new entrants to make informed decisions regarding the production and licensing of goods and services. Organizations, distributors and exporters should find useful information regarding market development and trends. The study segments the market on the basis of product type, such as POC PCR analyzers, consumables, single analyte, multi-analyte and applications. Geographical market analysis is provided for all the major segments. The report offers country-level analysis of markets to provide a better understanding of the major segments.
The market is divided into segments and by application/industry:
By Product type:
POC PCR analyzers.
Consumables.
By analyte:
POC PCR analyzers.
Single analyte.
Multi-analyte.
Consumables.
Single analyte.
Multi-analyte.
By Application:
Infectious diseases.
Sexually transmitted diseases (STIs).
Other diseases.
Each area is covered in detail, identifying current products in the market in the base year (2023), measuring the current market size and identifying current and potential market drivers, forecasting for 2029, assessing current and potential competitors, and identifying current competitor market shares for 2023.
Report Includes
53 data tables and 29 additional tables
An overview of the global market for polymerase chain reaction (PCR) for point-of-care (POC) diagnostics, along with an evaluation of each market segment’s future commercial potential
Analysis of global market trends, featuring revenue data for 2021-2023, estimates for 2024, and projected CAGRs through 2029
Evaluation of the current market size and revenue growth prospects, along with a market share analysis by product, analyte, application and region
Identification of emerging market opportunities, technology trends and issues, and regulatory frameworks pertaining to PCR technology
A look at the competitive landscape, including an analysis of the impact of COVID-19 as well as the FDA’s contribution to COVID-19 diagnostic testing
A review of patents and new developments in PCR POC technologies
Profiles of leading market participants, including Abbott, Danaher (Cepheid), Roche, Thermo-Fisher Scientific and QIAGEN
Companies MentionedABBOTT
CREDO DIAGNOSTICS BIOMEDICAL PTE. LTD.
DANAHER CORP.
F. HOFFMANN-LA ROCHE LTD.
QIAGEN
QUANTUMDX GROUP LTD.
THERMO FISHER SCIENTIFIC INC.
VISBY MEDICAL INC.